Xiangxue Pharmaceutical (300147.SZ) stated on the investor interaction platform on June 26 that the company's main business is the research and development, production, and sales of modern traditional Chinese medicine and traditional Chinese medicine granules. The "Xiangxue" trademark has been awarded the Chinese well-known trademark, and the main product is a well-known brand in Guangdong Province, with a great influence in the markets of South China and even the entire country. The company has established Chinese medicinal material production bases in Ningxia, Sichuan, Yunnan, and Guangdong, and has established processing bases and Chinese medicinal material trading markets using the rich Chinese medicinal material resources in those areas. The entire process of Chinese medicinal material production and cultivation, harvesting, processing, packaging, and transportation is managed in a standardized manner. At present, a complete industry chain layout of "Chinese medicinal material planting - production of traditional Chinese medicine granules - manufacturing of Chinese patent medicine - pharmaceutical circulation - new drug development" has been formed.
香雪制药(300147.SZ)：已在宁夏、四川、云南、广东等地建立了中药材生产基地
Xiangxue Pharmaceutical (300147.SZ) has established traditional Chinese medicine production bases in Ningxia, Sichuan, Yunnan, Guangdong and other places.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.